Magellan Diagnostics

company

About

Magellan Biosciences is provider of point-of-care analyzers and automated systems for hospital-based labs and near-patient testing.

  • 11 - 50

Details

Last Funding Type
Private Equity(PE)
Last Funding Money Raised
$50M
Industries
Health Care,Health Diagnostics,Medical
Founded date
Jan 1, 1960
Number Of Employee
11 - 50
Operating Status
Active

Lead poisoning threatens millions of people, yet is entirely preventable. Our mission is to help identify and protect those at risk.

Magellan Diagnostics is a medical device company that provides point-of-care systems, clinical laboratory instruments, and analytical laboratory services focused on lead testing. Headquartered outside Boston in Billerica, Massachusetts, Magellan is dedicated to offering high-quality, reliable products that help identify children and adults at risk of harm due to lead exposure.

Magellan Diagnostics has been a pioneer in the analysis of blood lead since the late 1960s, when the company (then called ESA, Inc.) was founded by four PhD graduates from the Massachusetts Institute of Technology (MIT). Applying a novel technique called Anodic Stripping Voltammetry (ASV), they designed and built a bench top analyzer for the measurement of lead in blood. The company then adapted this technology to create smaller, portable instruments that can be used outside of the traditional reference laboratory. This major achievement broadened the accessibility of lead testing by bringing it to the point of care.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$50M
Magellan Diagnostics has raised a total of $50M in funding over 2 rounds. Their latest funding was raised on Nov 29, 2006 from a Private Equity(PE) round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 29, 2006 Private Equity(PE) $50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Magellan Diagnostics is funded by 1 investors. New England Partners are the most recent investors.
Investor Name Lead Investor Funding Round
New England Partners Private Equity(PE)